CPSC Streamlined Rule on Certification
Client Alert | 1 min read | 11.12.08
On November 11, 2008, the Consumer Product Safety Commission ("CPSC") issued an immediately-effective final rule (16 CFR pt. 1110) streamlining certification requirements under the Consumer Product Safety Improvement Act of 2008 ("CPSIA") for foreign manufacturers and private labelers. [Click the link above to download a PDF of the final rule]
For imported products, the final rule designates the importer as "the sole entity that must issue the certificate required." The certificate must be available upon request when the product or shipment is available for inspection in the United States.
For domestically produced products, the final rule designates the domestic manufacturer as the sole entity required to issue the certificate. The certificate must be available upon request before the product or shipment is introduced into domestic commerce.
The final rule establishes that the required certificates may be available in electronic form for purposes of "accompanying" a shipment and being "furnished" to distributors and retailers. An acceptable electronic form is a unique identifier for the electronic version of the certificate accessible by a World Wide Web URL or other electronic means.
The CPSC cited the "extremely short deadline" for compliance with the certification requirement, the "vast expansion" of products covered by the requirement, and the confusion over the requirement as its justifications for streamlining the rule, "at least in its initial phase." The certification requirements established by the CPSIA go into effect for products manufactured on or after November 12, 2008.
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
